This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Shares of Dov Pharmaceutical (DOVP) were among the best-performing health-related stocks Monday, rising 9% after the company said its non-narcotic painkiller did well in a phase III clinical trial.

The company said that bicifadine, which was given to patients following bunionectomy surgery, showed statistically and clinically significant analgesic effects at 400 milligrams administered three times a day when compared to a placebo. Bicifadine was well tolerated and showed no serious side effects. The trial is the first of four phase III trials that are required for submission of a new drug application to the Food and Drug Administration. Shares were trading up $1.40 to $17.38.

Isis Pharmaceuticals (ISIS) rose 1% after the company said it expects to receive nearly $4 million from Alnylam Pharmaceuticals (ALNY - Get Report) as a result of Alnylam's alliance with Novartis (NVS - Get Report) for the development of RNA interference therapeutics. Isis also has the potential to receive milestone and royalty payments on drugs that utilize the Isis technology licensed to Alnylam.

"Leveraging our intellectual property position through licensing agreements, such as the agreement with Alnylan, allows us to realize significant value from our inventions in oligonucleotide chemistry and antisense mechanisms, including RNAi," Isis said. Shares of Isis were recently trading up 6 cents to $5.48.

Shares of Genaera (GENR) fell 11% after the company said it would sell 11.4 million shares of stock at $2.15 apiece in a direct equity placement. The sale price represents an 18% discount to Friday's closing price of $2.62 a share. The offering is expected to close on or about Sept. 13. Shares were trading down 30 cents to $2.32.

Geron (GERN - Get Report) fell 1% after the company said it would sell 6 million shares of stock. Meanwhile, the company said that Merck (MRK - Get Report) would concurrently exercise its warrant to purchase $18 million of Geron stock. The stock sale is being co-managed by SG Cowen, Needham & Co., and Lazard Capital Markets. UBS Investment Bank is acting as sole book running manager. Shares were trading down 12 cents to $11.60.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALNY $59.22 -2.29%
GERN $2.64 0.96%
ISIS $56.88 2.62%
NVS $72.62 -0.77%
MRK $49.16 0.68%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs